Coronavirus
Section Editor(s): Ronald Ellis, Biotech and Biopharma, Jerusalem, IL
COVID-19 vaccine, SARS-CoV2, research, development, biotechnology, preclinical, clinical, safety, epidemiology, cost, economics, and other coronaviruses.
Filters
Show filters
More subjects within
No subjects within
Selected filters
Clear all filters
- Letter to the Editor Remove selected filter:
- Human Vaccines & Immunotherapeutics
- 06/18/2023 - 06/18/2024 Remove selected filter:
- Coronavirus
Modify your search
Human Vaccines & Immunotherapeutics sections
-
Showing 11-18 of 18 results for search:
Filters